References

Brennan, C.A., S.L. Stramer, V. Holzmayer, J. Yamaguchi and G.A. Foster et al., 2009. Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors. Transfusion, 49: 125-133.
PubMed  |  

Church, J.D., D. Jones, T. Flys, D. Hoover and N. Marlowe et al., 2006. Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 Subtypes A, C and D. J. Mol. Diagn., 8: 430-432.
CrossRef  |  

Eshleman, S.H., J. Jr. Hackett, P. Swanson, S.P. Cunningham and B. Drews et al., 2004. Performance of the celera diagnostics ViroSeq HIV-1 genotyping system for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. J. Clin. Microbiol., 42: 2711-2717.
PubMed  |  

Felsenstein, J., 1988. Phylogenies from molecular sequences: Inference and reliability. Ann. Rev. Genet., 22: 521-565.
PubMed  |  

Geretti, A.M., 2006. HIV-1 subtypes: Epidemiology and significance for HIV management. Curr. Opin. Infect. Dis., 19: 1-7.
PubMed  |  

Holguin, A., M. Lopez, M. Molinero and V. Soriano, 2008. Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1 and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants. J. Clin. Microbiol., 46: 2918-2923.
PubMed  |  

Kantor, R., D.A. Katzenstein, B. Efron, A.P. Carvalho and B. Wynhoven et al., 2005. Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration. PLoS Med., 2: e112-e112.
PubMed  |  

Kumar, S. and S.R. Gadagkar, 2000. Efficiency of the neighbor-joining method in reconstructing deep and shallow evolutionary relationships in large phylogenies. J. Mol. Evol., 51: 544-553.
PubMed  |  

Lin, H.H., B.K. Gaschen, M. Collie, M. El-Fishaway and Z. Chen et al., 2006. Genetic characterization of diverse HIV-1 strains in an immigrant population living in New York City. J. Acquir. Immune. Defic. Syndr., 41: 399-404.
PubMed  |  

Martinez-Cajas, J.L., N.P. Pai, M.B. Klein and M.A. Wainberg, 2009. Differences in resistance mutations among HIV-1 non-subtype B infections: A systematic review of evidence (1996-2008). J. Int. AIDS Soc., 12: 11-11.
PubMed  |  

Palma, A.C., F. Araujo, V. Duque, F. Borges, M.T. Paixao, R. Camacho and Portuguese SPREAD Network, 2007. Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal. Infect. Genet. Evol., 7: 391-398.
CrossRef  |  

Peeters, M., A.F. Aghokeng and E. Delaporte, 2010. Genetic diversity among human immunodeficiency virus-1 non-B subtypes in viral load and drug resistance assays. Clin. Microbiol. Infect., 16: 1525-1531.
CrossRef  |  

Robertson, D.L., J.P. Anderson, J.A. Bradac, J.K. Carr and B. Foley et al., 2000. HIV-1 nomenclature proposal. Science, 288: 55-56.
PubMed  |  

Roques, P., D.L. Robertson, S. Souquiere, F. Damond and A. Ayouba et al., 2002. Phylogenetic analysis of 49 newly derived HIV-1 group O strains: High viral diversity but no group M-like subtype structure. Virology, 302: 259-273.
PubMed  |  

Soto-Ramirez, L.E., R. Rodriguez-Diaz, A.S. Duran, M.H. Losso and H. Salomon et al., 2008. Antiretroviral resistance among HIV type 1-infected women first exposed to antiretrovirals during pregnancy: Plasma versus PBMCs. AIDS Res. Hum. Retroviruses, 24: 797-804.
PubMed  |  

Swofford, D.L., 2002. PAUP*. Phylogenetic Analysis Using Parsimony (*and other Methods). Version 4.0, Sinauer Associates Inc., Sunderland, Massachusetts.

Yang, Z., R. Morrison, O. Oates, J. Sarria and J. Patel et al., 2008. HIV-1 genotypic resistance testing on low viral load specimens using the Abbott ViroSeq HIV-1 genotyping system. Lab. Medicine, 39: 671-673.
CrossRef  |  Direct Link  |